Market Cap

$11.1B

Volume

2.1M

Cash and Equivalents

$530.2M

EBITDA

-$68.9M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$1.9B

Profit Margin

73.19%

52 Week High

$85.15

52 Week Low

$40.62

Dividend

N/A

Price / Book Value

3.47

Price / Earnings

-62.45

Price / Tangible Book Value

-10.89

Enterprise Value

$12.9B

Enterprise Value / EBITDA

-571.54

Operating Income

-$282.3M

Return on Equity

-5.60%

Return on Assets

-2.71

Cash and Short Term Investments

$946.8M

Debt

$2.8B

Equity

$3.2B

Revenue

$2.6B

Unlevered FCF

$14.1M

Sector

Biotechnology

Category

N/A